Grant: Strategic Projects - Group
École Polytechnique de Montréal
$168,000.00
Enhanced optical multianalyte detection lab on chip for point-of-care diagnostic
EF 2008-09
Résumé
This proposal is addressing challenges that Canada will face in the next few decades. As seen recently on the
international scene, emerging and re-emerging infectious diseases, such as SARS, avian flu, and pathogens,
such as West Nile virus, HCV and others might threaten population. This problem is magnified due to the
increasing fraction of elderly individuals in the population. To address these issues, Canada will need advanced
biomedical technologies for early detection of infectious diseases in humans and also in animals. Current blood
tests can require days and even weeks to confirm a diagnosis of the presence of a pathogen and other infectious
diseases in a patient. The development of affordable diagnostic technologies, such as Point-of-Care Testing
(POTC) devices, in the form of hand-held, finger-prick blood sampling devices will provide for more timely
and accurate test results. POTC is extremely interesting since it can be performed at the site of the patient care,
such as in emergency rooms, battlefields, outpatient clinics, nursing homes, patients' homes or hospital bedside,
with the result leading to possible change in the care of the patient.
The proposed research fully corresponds to this vision and aims to develop nano- and microtechnologies that
will target a much shorter diagnosis time combined with an exceptional limit of detection. To this purpose we
plan to develop novel ultra-sensitive tunable photonic crystals (PhCs) that will be used at specific optical
resonances to detect bio-labeled quantum dots (QDs). It is envisioned that the sensitivity enhancement will be
such that the time consuming DNA extraction and PCR amplification steps usually needed prior to the analysis
might be eliminated. This would of course lead to a drastic reduction of the analysis time. In addition, in
contrast to conventional fluorophores, QDs that have extremely narrow emission spectra, will allow to move
beyond single parameter biochemical paradigms towards routine multianalyte detection schemes.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
336830-2006
Name nom
Peter, YvesAlain
Department département
Génie physique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
168000
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
3
Nb partie
3
Application title
Enhanced optical multianalyte detection lab on chip for point-of-care diagnostic
Keyword
NA
Application summary
This proposal is addressing challenges that Canada will face in the next few decades. As seen recently on the
international scene, emerging and re-emerging infectious diseases, such as SARS, avian flu, and pathogens,
such as West Nile virus, HCV and others might threaten population. This problem is magnified due to the
increasing fraction of elderly individuals in the population. To address these issues, Canada will need advanced
biomedical technologies for early detection of infectious diseases in humans and also in animals. Current blood
tests can require days and even weeks to confirm a diagnosis of the presence of a pathogen and other infectious
diseases in a patient. The development of affordable diagnostic technologies, such as Point-of-Care Testing
(POTC) devices, in the form of hand-held, finger-prick blood sampling devices will provide for more timely
and accurate test results. POTC is extremely interesting since it can be performed at the site of the patient care,
such as in emergency rooms, battlefields, outpatient clinics, nursing homes, patients' homes or hospital bedside,
with the result leading to possible change in the care of the patient.
The proposed research fully corresponds to this vision and aims to develop nano- and microtechnologies that
will target a much shorter diagnosis time combined with an exceptional limit of detection. To this purpose we
plan to develop novel ultra-sensitive tunable photonic crystals (PhCs) that will be used at specific optical
resonances to detect bio-labeled quantum dots (QDs). It is envisioned that the sensitivity enhancement will be
such that the time consuming DNA extraction and PCR amplification steps usually needed prior to the analysis
might be eliminated. This would of course lead to a drastic reduction of the analysis time. In addition, in
contrast to conventional fluorophores, QDs that have extremely narrow emission spectra, will allow to move
beyond single parameter biochemical paradigms towards routine multianalyte detection schemes.